Perioperative medicine & outcomes

Implementation of a kidney protection strategy to prevent acute kidney injury after major surgery in high-risk patients identified by biomarkers: a systematic review and individual participant data meta-analysis of randomized controlled trials

Intensive Care MedPublished Systematic review and individual participant data meta-analysis of randomised controlled trials

Pooled resultResult — go to the resultOdds ratio 0.55 95% CI 0.44–0.70

Authors' conclusion

The implementation of a kidney protection strategy reduces the rates of moderate or severe AKI in biomarker-enriched high-risk patients after major surgery compared to standard of care, while the incremental clinical value of biomarker-guided selection itself remains uncertain.

Study context

Population
High-risk patients after major surgery identified by renal biomarkers
Participants
1,851 patients · 4 randomized controlled trials (RCTs)
Comparison
KDIGO kidney protection strategy vs standard care
  • Interventionn = 921
  • Controln = 930reference
Outcome
Moderate or severe AKI (KDIGO stage ≥ 2)
Follow-up
72 h after surgery
Methodological detailsone-stage individual participant data (IPD) meta-analysis, biomarker-based enrichment strategy, GRADE
  • One-stage IPD meta-analysis
  • Biomarker-based enrichment strategy
  • GRADE

Pooled result

As reported in the abstract

Odds ratio

0.55

95% CI 0.44–0.70

P < 0.0001

Events by group

Intervention vs Control
OR 0.55 (95% CI 0.44–0.70); P < 0.0001
No evidence of heterogeneity across studies
I2 = 0.0%

Further pooled results

Secondary endpoints

Varied across trials; no major differences between groups

Persistent acute kidney injury (AKI) and renal tubular stress biomarkers

Intervention tended to result in fewer persistent AKI events and larger decreases in renal tubular stress biomarkers
  • When measured

Original publication

Implementation of a kidney protection strategy to prevent acute kidney injury after major surgery in high-risk patients identified by biomarkers: a systematic review and individual participant data meta-analysis of randomized controlled trials. Intensive Care Med. Published 20 April 2026. doi:10.1007/s00134-026-08399-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.